mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.32 |
2e-17 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.32 |
7e-16 |
mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
0.31 |
4e-15 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
8e-14 |
mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
1e-13 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
2e-12 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
5e-12 |
mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
0.29 |
9e-12 |
mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
1e-11 |
mRNA |
PF-573228 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
3e-11 |